| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 3.35B | 7.10% |
| Operating expense | — | — |
| Net income | 402.00M | 11.98% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HKMPF returned -6.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +9.0% |
| 1 year | -6.9% |
| 5 years | -36.5% |
| 10 years | -18.4% |
| All-time high | $37.00 (Jul 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in HKMPF would be worth today ›Yes. Hikma Pharmaceuticals PLC paid 1 dividend over the past 12 months. The most recent was $0.48 per share on Mar 19, 2026. The dividend yield is 3.88%.
Hikma Pharmaceuticals PLC is part of the Healthcare sector.
Hikma Pharmaceuticals PLC has a market cap of 3.95B USD, based on the latest quote.
